As Table II shows, the CD34, GPC-3, GS, HSP70, Ki-67 and PEG10 biomarkers had a positive rate of >90% and the novel biomarker CHCHD2 was expressed in HCC. This evidence concerns the gene CD34 and hepatocellular carcinoma.